NIBAN1 and renal carcinoma: Feng et al. (2019) demonstrated that NIBAN1 interacts with the TIMP-1/MMP2/MMP9 pathway, interfering with the processes of cell migration, invasion and proliferation, in clear cell renal carcinoma (ccRCC), the most aggressive subtype of renal cancer, contributing to tumor progression.